Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D B Dixon

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Journal of Medicinal Chemistry|February 16, 1996
Azole endothelin antagonists. 3. Using delta log P as a tool to improve absorptionT W von Geldern, D J Hoffman, J A Kester, et al.
Journal of Medicinal Chemistry|September 10, 1999
Pyrrolidine-3-carboxylic acids as endothelin antagonists. 4. Side chain conformational restriction leads to ET(B) selectivityT W von Geldern, A S Tasker, B K Sorensen, et al.
Journal of Medicinal Chemistry|January 31, 1997
Potent and selective non-benzodioxole-containing endothelin-A receptor antagonistsA S Tasker, B K Sorensen, H S Jae, et al.
European Journal of Pharmacology|March 19, 1999
Pharmacology of A-216546: a highly selective antagonist for endothelin ET(A) receptorJ R Wu-Wong, D B Dixon, W J Chiou, et al.
Journal of Medicinal Chemistry|August 14, 1998
Pyrrolidine-3-carboxylic acids as endothelin antagonists. 3. Discovery of a potent, 2-nonaryl, highly selective ETA antagonist (A-216546)G Liu, K J Henry, B G Szczepankiewicz, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1996
Pharmacological characterization of A-127722: an orally active and highly potent ETA-selective receptor antagonistT J Opgenorth, A L Adler, S V Calzadilla, et al.
Bioorganic & Medicinal Chemistry|July 31, 1999
Discovery of a series of pyrrolidine-based endothelin receptor antagonists with enhanced ET(A) receptor selectivityS A Boyd, R A Mantei, A S Tasker, et al.
Journal of Medicinal Chemistry|March 1, 1996
2,4-Diarylpyrrolidine-3-carboxylic acids--potent ETA selective endothelin receptor antagonists. 1. Discovery of A-127722M Winn, T W von Geldern, T J Opgenorth, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal of Medicinal Chemistry|February 16, 1996
Azole endothelin antagonists. 3. Using delta log P as a tool to improve absorptionT W von Geldern, D J Hoffman, J A Kester, et al.
Journal of Medicinal Chemistry|September 10, 1999
Pyrrolidine-3-carboxylic acids as endothelin antagonists. 4. Side chain conformational restriction leads to ET(B) selectivityT W von Geldern, A S Tasker, B K Sorensen, et al.
Journal of Medicinal Chemistry|January 31, 1997
Potent and selective non-benzodioxole-containing endothelin-A receptor antagonistsA S Tasker, B K Sorensen, H S Jae, et al.
European Journal of Pharmacology|March 19, 1999
Pharmacology of A-216546: a highly selective antagonist for endothelin ET(A) receptorJ R Wu-Wong, D B Dixon, W J Chiou, et al.
Journal of Medicinal Chemistry|August 14, 1998
Pyrrolidine-3-carboxylic acids as endothelin antagonists. 3. Discovery of a potent, 2-nonaryl, highly selective ETA antagonist (A-216546)G Liu, K J Henry, B G Szczepankiewicz, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1996
Pharmacological characterization of A-127722: an orally active and highly potent ETA-selective receptor antagonistT J Opgenorth, A L Adler, S V Calzadilla, et al.
Bioorganic & Medicinal Chemistry|July 31, 1999
Discovery of a series of pyrrolidine-based endothelin receptor antagonists with enhanced ET(A) receptor selectivityS A Boyd, R A Mantei, A S Tasker, et al.
Journal of Medicinal Chemistry|March 1, 1996
2,4-Diarylpyrrolidine-3-carboxylic acids--potent ETA selective endothelin receptor antagonists. 1. Discovery of A-127722M Winn, T W von Geldern, T J Opgenorth, et al.
Pageof 3